Bicycle Therapeutics (BCYC) Shares Issued (2018 - 2026)

Bicycle Therapeutics has reported Shares Issued for 8 years, with the latest figure at $12000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 500.0% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2026 stood at $47000.0 (down 99.17% YoY), and the FY2025 full-year result was $37000.0, down 99.51% from the prior year.
• Shares Issued for Q1 2026 stood at $12000.0, down from $33000.0 in the prior quarter.
• The five-year high for Shares Issued was $19.4 million in Q3 2023, with the low at -$248.7 million in Q4 2023.
• Historically, Shares Issued has averaged -$12.0 million across 5 years, with a median of $195000.0 in 2022.
• Annual changes were most pronounced in 2023 — Shares Issued tumbled 5175.59% — and 2024, when it jumped 93450.0%.
• Bicycle Therapeutics' Shares Issued stood at $4.9 million in 2022, then plunged by 5175.59% to -$248.7 million in 2023, then soared by 100.1% to $245000.0 in 2024, then sank by 86.53% to $33000.0 in 2025, then plunged by 63.64% to $12000.0 in 2026.
• The last three Shares Issued figures came in at $12000.0 (Q1 2026), $33000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.